How to Choose ICU Ventilators

A procurement guide for hospital biomedical engineers, respiratory therapy directors, and critical care administrators evaluating full-feature mechanical ventilation systems.

---

What this is and who buys it

An ICU ventilator is a life-sustaining device that assumes or augments a patient's breathing when they cannot maintain adequate gas exchange on their own. Unlike transport or subacute ventilators, a critical care ventilator is engineered for the sustained, high-acuity demands of medical, surgical, cardiac, and neurological intensive care — environments where patients may remain ventilated for days to weeks and where the device must respond to rapidly changing lung mechanics without interruption. The governing performance standard, ISO 80601-2-12:2023, explicitly frames these as life-sustaining devices intended for environments that provide "specialized care for patients whose conditions can be life-threatening" [S1].

The primary buyers are hospital procurement teams working alongside biomedical/clinical engineering departments and respiratory therapy (RT) directors. A fleet refresh is typically triggered by aging inventory crossing the 10–14-year mark, an expansion of licensed ICU beds, or a post-pandemic strategic review of surge capacity. Individual units routinely price above $25,000 at the full-feature tier; a 20-bed ICU re-fleet can easily approach or exceed $1 million before service contracts and accessories are counted, making this one of the larger single-category capital expenditures a clinical engineering department will manage.

Interest in the category has accelerated since 2020, when supply-chain vulnerabilities in ventilator availability became a patient-safety issue at scale. Many IDNs are now carrying a deliberate strategic reserve — often 15–25% above operational census — and procurement decisions increasingly blend primary-duty full-feature units with lower-cost secondary platforms appropriate for surge or step-down use.

---

Key decision factors

Patient population coverage is the first gate. Not all ICU ventilators are cleared for the same patient sizes, and the labeling difference matters legally. The HAMILTON-C6, for example, carries 510(k) clearance for adults, pediatric, infant, and neonatal patients for both invasive and noninvasive ventilation [S2], while the Mindray SV600/SV800 is cleared for adults and pediatric patients with a minimum body weight of 10 kg, explicitly excluding neonates [S3]. A mixed adult/PICU service procuring a single platform must verify on-label coverage rather than relying on vendor sales assurances.

Ventilation modes determine clinical versatility over the device's service life. At minimum, an ICU ventilator should deliver assist/control and SIMV in both volume- and pressure-controlled variants, plus CPAP/PEEP and pressure support, with continuous monitoring of airway pressure, respiratory rate, I:E ratio, and minute volume [S7]. Mid- and high-tier platforms differentiate themselves with closed-loop modes — Adaptive Support Ventilation (ASV), Proportional Assist Ventilation Plus (PAV+), and Neurally Adjusted Ventilatory Assist (NAVA) — that can reduce ventilator-patient dyssynchrony and have been associated with shorter weaning times in clinical studies. Whether your RT staff will actually use those modes should factor into whether the premium is justified.

Tidal volume range and trigger sensitivity become critical in pediatric contexts. Children represent roughly 25% of the general population, and a ventilator deployed in a mixed or pediatric ICU needs to deliver tidal volumes reliably in the 30–50 mL range with appropriately sensitive flow or pressure triggers [S7]. Units that bottom out at 50–100 mL are unsuitable for smaller pediatric patients regardless of other capabilities.

Internal battery vs. external UPS is a frequently underweighted specification. External uninterruptible power supplies add cost, floor space, and failure points; industry guidance recommends specifying internal batteries wherever possible [S7]. Minimum runtime expectations typically range from 30 minutes (adequate for brief power events and intra-hospital transport) to 120 minutes for facilities with longer generator transfer times or frequent intra-hospital moves. Hot-swap battery capability — allowing battery replacement without interrupting ventilation — is available on select platforms and should be specified if your patient population or facility layout makes it relevant.

Turbine vs. compressed-gas drive affects both infrastructure dependencies and transport flexibility. Turbine-driven platforms (common in the Hamilton-C series) operate without a 50 psi medical air wall supply, making them inherently portable within the facility and lower-risk in gas-supply disruption scenarios. Pneumatically driven piston units require reliable medical air delivery; in facilities where wall air quality or pressure regularity is variable, that is a meaningful operational constraint worth surfacing before a purchase decision.

Graphics, monitoring, and decision support have moved from differentiator to baseline expectation. Pressure-time, flow-time, and volume-time scalars, plus flow/volume and pressure/volume loops, are now standard for waveform-based lung-protective monitoring [S7]. Advanced modules — end-tidal CO2 (EtCO2), esophageal pressure, and transpulmonary pressure — allow more nuanced assessment of respiratory mechanics and patient effort. Evaluate which modules are included in the base price versus priced as separate licensed options, as this can add $5,000–$15,000 per unit to the true cost.

Interoperability and cybersecurity are increasingly non-negotiable. HL7 integration with Epic and Cerner enables automated charting of ventilator parameters, reducing transcription burden and supporting sepsis and ARDS bundles. Cybersecurity posture — including network segmentation capability, signed firmware updates, and a publicly available MDS2 form — is now a reasonable procurement requirement following FDA guidance on medical device cybersecurity and applicable HIPAA obligations for any unit that stores or transmits protected health information.

---

What it costs

ICU ventilator pricing spans a wide range depending on patient population coverage, mode depth, monitoring capability, and whether the unit is new or refurbished. Publicly listed prices are uncommon — most contracts are negotiated — but the following bands reflect current market positioning based on published advisory data [S7, S9]:

• Entry: $15,000–$25,000 — Basic adult-only ICU ventilators or refurbished mainstream platforms. Suitable for step-down or surge reserve roles where closed-loop modes and advanced graphics are not required.
• Mid-tier: $25,000–$50,000 — Full-feature adult/pediatric ventilators with advanced waveform graphics, NIV capability, and commonly at least one closed-loop or automation mode. The most common acquisition tier for new primary-duty fleet units.
• Premium: $50,000–$80,000+ — Neonatal-capable platforms, closed-loop modes (ASV, NAVA, INTELLiVENT), and integrated capnography as standard. Some fully configured neonatal/critical care platforms with all licensed options exceed $100,000 per unit.

Refurbished units from OEM-certified programs can come in 20–40% below comparable new-unit pricing [S9], though remaining service life and firmware support horizon must be verified contractually before that discount is treated as a real saving.

---

Common use cases

ICU ventilators serve a broader range of clinical contexts than the name implies, and understanding deployment environment shapes which specifications to prioritize. A cardiac surgical ICU has different weaning-protocol requirements than a medical ICU managing ARDS at high PEEP, and neither maps neatly onto a PICU serving 8 kg toddlers.

• Medical, surgical, cardiac, and neuro ICUs — Invasive ventilation of ARDS, sepsis-related respiratory failure, post-operative recovery, and COPD exacerbations. High PEEP tolerance, advanced waveform monitoring, and closed-loop weaning modes are valued.
• Step-down / progressive care units — Noninvasive ventilation (BiPAP, high-flow CPAP) and active weaning protocols. A mid-tier unit with strong NIV mode implementation often suffices and avoids over-investing in features that won't be clinically used.
• PICUs and NICUs — Only with platforms carrying appropriate on-label clearance. The Dräger Evita XL, for example, holds clearance for adults, children, and neonates down to a minimum body weight of 3 kg [S5]; the Getinge SERVO-U similarly covers a broad weight range [S4]. Verify labeling before assuming a standard ICU platform covers neonatal use.
• Intra-hospital transport and surge reserves — Critical care ventilators can function as transit-operable devices within a professional healthcare facility [S7], distinct from dedicated transport ventilators governed by ISO 80601-2-84. Surge-reserve slots are often filled with OEM-refurbished units at entry-tier pricing, which is an appropriate use of that cost point.

---

Regulatory and compliance

ICU ventilators are regulated by the FDA as Class II devices under 21 CFR 868.5895 (Continuous Ventilator), product code CBK, cleared through the 510(k) premarket notification pathway under the Anesthesiology device panel. Buyers should request and verify the specific 510(k) number for any platform under evaluation; FDA's public 510(k) database allows confirmation of indicated patient population, cleared modes, and any post-clearance recalls or corrections.

The primary performance standard is ISO 80601-2-12:2023, which sets requirements for basic safety and essential performance of critical care ventilators [S1]. Supporting standards include IEC 60601-1 (general electrical safety), IEC 60601-1-2 (electromagnetic compatibility), IEC 60601-1-8 (alarm systems), IEC 62304 (medical device software lifecycle), and the ISO 18562 series covering biocompatibility of gas pathways. Joint Commission compliance falls under EC.02.04.01, which governs the medical equipment management program and requires documented PM intervals and records. Any ventilator integrated with the EMR that stores or transmits patient data triggers HIPAA obligations; request a completed MDS2 form and confirm the vendor's patch cadence as part of due diligence.

---

Service, training, and total cost of ownership

The acquisition price of an ICU ventilator is genuinely not a reliable proxy for what it will cost to operate over its service life [S7]. Commissioning requires vendor-led installation, electrical safety testing per NFPA 99 and IEC 60601-1, and biomed acceptance testing per ECRI Procedure 458 [S6]. For a new fleet platform unfamiliar to your RT staff, allow for a meaningful training ramp: touch-screen interfaces lower the physical learning curve, but mode logic, alarm philosophy, and closed-loop behavior can take weeks of supervised clinical use before teams reach full utilization.

Preventive maintenance intervals are typically structured at monthly biomed inspections, daily or weekly RT safety checks, and formal internal service at 6-, 12-, and 24-month intervals aligned with manufacturer PM kit schedules — with specific intervals often tied to hours of use rather than calendar time alone [S7]. Oxygen sensors typically require replacement every one to two years [S7]. Internal batteries will need replacement three to six times over a ventilator's life at $300–$800 per battery depending on platform [S9] — a cost that is easy to overlook in capital-budget planning but adds up materially across a fleet. Expected service life is commonly cited as 7–14 years with proper maintenance, and some well-maintained platforms exceed that range [S9]; confirm in writing that the vendor will support parts and firmware for a minimum of seven to ten years post-purchase. For fleets exceeding 20 units, evaluating whether biomed staff can be OEM-certified to perform in-house repairs at Level 2 or 3 typically yields meaningful savings over full-coverage service contracts.

---

Red flags to watch for

Negotiate service contract pricing before the purchase order is signed, not after — ECRI explicitly identifies post-PO negotiation as a significant loss of leverage for the buyer [S7]. A vendor who cannot or will not provide the 510(k) clearance number, predicate device listing, or domestic recall history on request should be treated as a serious red flag; that documentation is publicly available and there is no legitimate reason to withhold it.

Be cautious about units that rely on an external UPS rather than an integrated hot-swap battery, particularly if the sales pitch frames this as equivalent functionality — it is not, especially for intra-hospital transport scenarios. Similarly, documented evidence that preventive maintenance was skipped or improperly recorded on a used unit under consideration is a disqualifying finding; research in clinical engineering has linked a material proportion of ventilator-related adverse events directly to incomplete PM execution [S8]. Finally, watch for pandemic-era rapid-deployment ventilators with limited mode sets and rudimentary graphics being remarketed as full-feature ICU platforms — verify mode depth and monitoring capability against the 510(k) labeling, not the sales brochure.

---

Questions to ask vendors

1. Provide the 510(k) clearance number, product code CBK, predicate devices, and confirm which edition of ISO 80601-2-12 was used for testing.
2. What is the on-label minimum patient weight, and is neonatal use cleared in the base configuration or as a paid add-on option?
3. What is the guaranteed parts and software support horizon from our purchase date, and what is the policy distinguishing free from paid firmware updates?
4. Provide the full PM kit schedule (6/12/24-month), kit unit pricing, oxygen sensor replacement interval, and internal battery cycle life and per-unit replacement cost.
5. What is the on-battery runtime at typical adult ICU settings, and is the internal battery hot-swappable without interrupting ventilation delivery?
6. What EMR integration is supported (Epic, Cerner), what cybersecurity documentation is available (MDS2, SBOM, patch cadence), and what is your disclosed vulnerability disclosure process?

---

Alternatives

The decision between new and refurbished, and between purchase and lease, is not binary — many IDNs run a tiered fleet where primary-duty ICU positions are filled with new units and surge or step-down capacity is met with OEM-certified refurbished platforms at 20–40% below comparable new pricing [S9]. Refurbished units are well-suited to that secondary role provided the refurbishment is documented to OEM standards, remaining service life is contractually stated, and firmware support is confirmed. The key risk with refurbished primary-duty units is acquiring a platform that is two or three firmware generations behind with a manufacturer no longer actively investing in its feature roadmap.

Operating leases over 36–60 months preserve capital budget and can bundle PM costs, but typically cost 15–25% more over the full term than outright capital purchase for units expected to run beyond seven years. Capital purchase is generally the better economics for primary ICU duty; rental or short-term lease is appropriate only for documented surge events or temporary gap-filling. On service coverage, a full-coverage service contract ensures PM cadence, eliminates unplanned repair costs, and — critically — many vendors will not extend uptime guarantees beyond the warranty period without one [S7]. For large fleets, the hybrid model of an OEM-trained in-house biomed team handling routine PM with a vendor-backed escalation path for major failures tends to offer the best balance of cost and coverage. A final strategic consideration: standardizing on a single vendor simplifies training, circuit inventory, and spare-parts management, but creates supply-chain concentration risk; many large health systems run a primary platform supplemented by a secondary brand sized to roughly 20% of fleet as a contingency hedge.

---

Sources

• ISO 80601-2-12:2023 — Critical care ventilators (basic safety and essential performance)
• FDA 510(k) K201658 — HAMILTON-C6 Ventilator (21 CFR 868.5895, Class II, CBK)
• FDA 510(k) K220107 — Mindray SV600/SV800 Ventilator
• FDA 510(k) K180098 — Getinge SERVO-U/n 2.1 Ventilator System
• FDA 510(k) K083050 — Dräger Evita XL
• ECRI BiomedicalBenchmark — Inspection and Preventive Maintenance Procedure 458 (Intensive Care Ventilators)
• HealthManagement.org / ECRI Institute — Intensive Care Ventilators: Purchase Considerations
• Respiratory Therapy — 7 Things You Should Know Before Investing in a Ventilator Fleet
• Heartland Medical — Mechanical Ventilator Cost and Lifespan
• Oxmaint — Ventilator Maintenance Checklist (TJC EC.02.04.01, AAMI alignment)